Article
Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia.
PloS one - 1 Jan 2020
Tamandjou Tchuem Cynthia Raissa, Brandt Laura, Nel Etienne De la Rey, Cotton Mark Fredric, Matthews Philippa, Kaindjee-Tjituka Francina, Preiser Wolfgang, Andersson Monique Ingrid
Abstract excerpt
In patients who are HIV infected, hepatitis B virus (HBV) infection is an important co-morbidity. However, antiretroviral options for HIV/HBV co-infected children are limited and, at the time of this study, only included lamivudine. These children may remain on this regimen for many years until late adolescence. They are at high risk of developing HBV drug resistance and uncontrolled HBV disease. The aim of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.